Prologis, a bio-tech company, has seen a considerable amount of financial activity in recent times. Its
Q4 2024 earnings results were revealed, disclosing pivotal fiscal data.
Cibc World Market Inc acquired 5,516 shares of Prologis, while multiple instances of shares being sold were noted, such as Sterling Investment Counsel and Fifth Third Bancorp. A few investment firms like BankPlus Wealth Management and Hixon Zuercher established
stock positions. Financial entities like UBS Group, RBC Capital, and Robert W. Baird updated the
price target for Prologis. Amplifying its market reach, Prologis crowned its year with the announcement of
2024 Dividend Tax Treatment Details. Goldman Sachs sustained a Neutral rating on ProLogis (PLD). A noteworthy mention is of the Q4 Funds From Operations (FFO) surpassing expectations, and rental revenues showing improvement. On the innovation aspect, Prologis introduced their
inaugural supply chain intelligence report, setting a new bar. Still, emphasis on
logistics real estate investment keeps soaring, furthering the belief that Prologis is a promising stock in this realm.
Prologis PLD News Analytics from Wed, 17 Apr 2024 07:00:00 GMT to Sat, 01 Feb 2025 12:04:47 GMT -
Rating 6
- Innovation 3
- Information 8
- Rumor -4
